Drug Approval | August 11, 2024
Granules India receives ANDA approval for Trazodone Tablets
Trazodone tablets are indicated for the treatment of major depressive disorder in adults
Trazodone tablets are indicated for the treatment of major depressive disorder in adults
Valbenazine Capsules had annual sales of US $1,993.6 mn in the United States (IQVIA MAT June 2024)
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
This product will be manufactured at Lupin’s Nagpur facility in India and will be supplied to low and middle-income countries
These gummies are specially formulated for both kids and adults to nourish the eyes and promote optimal vision development
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, India
Zydus receives final approval from USFDA for its NDA Zituvimeta, extended-release tablets
Subscribe To Our Newsletter & Stay Updated
